in clini cal use for ap proxi mately 35 years. Use of van comy cin has in creased sig nifi cantly over the past dec ade (1) largely be cause of the in creased preva lence of in fec tions due to coagulase-negative staphy lo cocci, of ten re lated to in travas cu lar and other pros thetic de vices. In some lo cales, the emer gence of methicillin-resistant Staphy lo coc cus au reus (MRSA) has been a ma jor fac tor con trib ut ing to in creased vanco mycin use.
It has be come stan dard prac tice to moni tor se rum van comy cin con cen tra tions rou tinely in pa tients re ceiv ing van co mycin (1) (2) (3) . Sen si tive, ac cu rate and easy to per form as says are read ily avail able, par ticu larly the fluo res cence po lar ized immu no as say. In the past sev eral years, the con ven tional wisdom of rou tine moni tor ing of se rum van co my cin con cen tra tions has been chal lenged (4) (5) (6) (7) . It is par ticu larly timely in light of di min ish ing heath care re sources in con junction with the growth of evidence-based medi cine that van comy cin se rum moni tor ing be re as sessed.
RATIONALE FOR THERAPEUTIC DRUG MONITORING
Re cently, Cantú et al (6) re it er ated the prin ci ples un der lying thera peu tic drug moni tor ing (TDM):
• There must be a reliable assay available.
• There must be a correlation between the serum drug concentration and clinical efficacy and/or drug toxicity.
• If a correlation between serum drug concentrations and either efficacy or toxicity is known, there must be significant interpatient variability in drug pharmacokinetics, such that predictable serum concentrations cannot be achieved with empirical or weight-based dosing regimens.
TDM AND AMINOGLYCOSIDES
With eight-hourly dos ing of most ami no gly cosides such as gen ta mi cin, all of the un der ly ing prin ci ples of TDM are pres ent and, there fore, rou tine moni tor ing is logi cal us ing this dos ing regi men. How ever, with once-daily ami no gly co side dos ing, it can be strongly ar gued that em piri cal weight-based dos ing regi mens will con sis tently re sult in both thera peu tic peak concen tra tions that take ad van tage of the drug's con cen tration-d epen dent kill ing, as well as low trough con cen tra tions to mini mize tox ic ity so that rou tine TDM is un nec es sary (8).
TDM AND VANCOMYCIN
As far as van co my cin is con cerned, there is no doubt that there is a re li able and easy to per form se rum drug as say. How ever, there is lit tle, if any, evi dence to sup port a cor re lation be tween any par ticu lar se rum van co my cin con cen tra tion range and clini cal ef fi cacy (3-7). Like wise, there are few data to sug gest that ad verse ef fects are re lated to any par ticu lar se rum con cen tra tion range (4-6). In deed, whether van co mycin alone is neph ro toxic or oto toxic is con tro ver sial, al though the bal ance of evi dence does sug gest that van co my cin poten ti ates ami no gly co side tox ic ity (7) . Fur ther more, stan dard van co my cin dos ing with 2 g/day (ei ther 1 g every 12 h or 500 mg every 6 h) in most adults with good re nal func tion (or 30 mg/kg/day for chil dren) con sis tently re sults in van co my cin peak con cen tra tions from 18 to 47 µg/mL and trough concen tra tions from 2 to 13 µg/mL. These con cen tra tions are in ex cess of the mini mum in hibi tory con cen tra tions for nearly all strains of S au reus and Strep to coc cus spe cies (9) .
Fi nally, the cost and dis com forts as so ci ated with se rum van co my cin moni tor ing must be con sid ered. Each pair of sam ples re sults in two ad di tional ve ne punc tures, and the cost of these two as says is ap proxi mately $38 on a cost re cov ery ba sis (per sonal com mu ni ca tion).
RECOMMENDATIONS
In view of the evi dence, we and oth ers (4-7) be lieve that rou tine moni tor ing of se rum van co my cin con cen tra tions is not in di cated and should not be per formed. How ever, there are a few se lect pa tient popu la tions in which se rum van co my cin moni tor ing should be con sid ered. The first group of pa tients is those with rap idly chang ing re nal func tion. The sec ond is patients re ceiv ing he mo dialy sis with high flux di aly sis membranes that are ca pa ble of re mov ing some van co my cin (10) . The third group of pa tients is those who ap pear not to re spond clini cally to van co my cin ther apy. For other pa tients, pe ri odic ADULT IN FEC TIOUS DIS EASE NOTES CAN J INFECT DIS VOL 6 NO 2 MARCH/APRIL 1995moni tor ing of se rum cre ati nine is suf fi cient to de tect when dose al tera tions should be made; these dose al tera tions can ef fec tively be made by a dos ing no mo gram (11) .
To con serve di min ish ing health care re sources, the util ity of all di ag nos tic tests must be criti cally evalu ated. Tests that add costs with out pro vid ing mean ing ful clini cal bene fits need to be aban doned. Rou tine se rum moni tor ing for van co my cin con cen tra tions clearly falls into this cate gory of tests. Our precious health care re sources can be far bet ter util ized.
